AMGEN Inc
NASDAQ: AMGN
$294.53
+$4.63 (+1.6%)
Closing Price on November 22, 2024
AMGN Articles
Amgen is expected to report its second-quarter financial results after the markets close on Wednesday. Will it go the same way as Gilead Sciences did earlier this week?
Published:
Last Updated:
The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected biotech stocks.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting their quarterly results this week.
Published:
Last Updated:
The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline potential at current levels.
Published:
Last Updated:
Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently be the case in the largest stocks in the biotech sector within health care if...
Published:
Last Updated:
The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. After all, a cure or...
Published:
Last Updated:
The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
One time when missing earnings estimates doesn't matter much is when there is bidding war for the company. That's the position that Medivation found itself in.
Published:
Last Updated:
With earnings having just been released for some of the top biotech companies, we saw a flurry of analyst calls by the week's end.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
Published:
Last Updated:
Regeneron Pharmaceuticals saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen on a cholesterol drug patent.
Published:
Last Updated: